SEC Form 4 · accession 0000899243-15-009480
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Williams Ph.D.
Officer — Executive Vice President
Period of report
Dec 5, 2015
Accepted (ET)
Dec 8, 2015 · 6:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 5, 2015 | M | 962 | $0.00 | A | 40,695 | D | |
| Common StockF2 | Dec 5, 2015 | F | 437 | $70.40 | D | 40,258 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF4,F3 | — | Dec 5, 2015 | M | 962 | D | — | — | Common Stock | 962 | 12,628 | D |
Explanation of responses
- F1The number of securities reported reflects a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015 (the "Stock Split") and includes 79 shares (without giving effect to the Stock Split) acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2015.
- F2Reflects the closing price of Issuer's common stock on the NASDAQ market on December 4, 2015.
- F3Represents restricted stock units previously granted on December 5, 2013 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date of the date of grant. The number of restricted stock units reported was adjusted to reflect the Stock Split.
- F4Not applicable.